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ABSTRACT
Objective: The present study was undertaken to investigate the thrombolytic activity of Punica granatum fruit and peel extract.
Methods: Phytoconstituents and free radical scavenging activity of P. granatum extract were performed. Ethanolic and aqueous extract of fruit and 
peel of the plant was used for in vitro clot lysis activity using streptokinase (SK) as standard. In a series of pre-weighed eppendorf tubes, equal volume 
of venous blood was collected and serum was removed and the tubes were weighed. The tubes containing clot were incubated with fruit, peel extract 
(100 ug/ml), and SK individually at 37°C for 60 minutes. After incubation, fluid obtained was removed, and tubes were again weighed to observe the 
difference in weight after clot disruption. The percent of clot lysis was determined.
Results: Free radical scavenging activity of the extracts was increased in a dose-dependent manner. Of the extracts, ethanolic extract showed 
maximum activity as compared with aqueous extract, whereas the ascorbic acid exerted maximum activity as compared with the extracts. Maximum 
thrombolytic activity (59%) was observed with ethanolic extract of peel of the fruit.
Conclusions: The present study concluded that the aqueous and ethanolic extracts of P. granatum fruit and peel possess thrombolytic activity.
Keywords: Punica granatum, Antithrombolytic activity, Antibacterial, Antioxidant, Phytochemicals.
INTRODUCTION
A blood clot (thrombus) developed in the circulatory system due to the 
failure of hemostasis causes vascular blockage and while recovering 
leads to serious consequences in atherothrombotic diseases such 
as myocardial or cerebral infarction, at times leading to death [1]. 
Thrombolytic agents that include tissue plasminogen activator, 
urokinase (UK), and streptokinase (SK) are used all over the world 
for the treatment of these diseases. In India, though SK and UK are 
widely used due to lower cost [2], as compared to other thrombolytic 
drugs, their use is associated with hyper risk of hemorrhage [3] severe 
anaphylactic reaction and lacks specificity. Moreover, as a result of 
immunogenicity multiple treatments with SK in a given patient are 
restricted [4]. Because of the shortcomings of the available thrombolytic 
drugs, attempts are underway to develop improved recombinant 
variants of these drugs.
Herbal products are often perceived as safe because they are 
“natural” [5]. In India, in recent years, there is increased research on 
traditional ayurvedic herbal medicines on the basis of their known 
effectiveness in the treatment of ailments for which they have been 
traditionally applied.
Although only recently has pomegranate (Punica granatum) been 
acclaimed for its health benefits, this fruit has long been cultivated 
and consumed, as fresh fruit or in the form of beverage, especially in 
the Mediterranean region. Pomegranate fruit, juice and peel possess 
a marked antioxidant capacity [6] with a high content in polyphenols, 
in particular, ellagitannins, condensed tannins, and anthocyanins [7]. 
Some of these antioxidant molecules has been shown to be bioavailable 
and safe [8]. Pomegranate juice has been proposed as chemopreventive, 
chemotherapeutic, anti-atherosclerotic, and anti-inflammatory [9], and 
accordingly its consumption has grown tremendously [8]. However, 
it would be important to confirm and characterize pomegranate juice 
in vivo effects on biological systems. The aim of the present work is to 
investigate the antithrombolytic activity of P. granatum fruit and peel 
extract.
METHODS
P. granatum fruit and peel were collected from Kumbakonam, identified 
and authenticated by the Department of Botany, Government Arts 
College (Autonomous), Kumbakonam, Tamil Nadu, India.
Preparation of extracts
Fruit extract
The fresh fruits were washed thoroughly to remove adhered materials. 
10 g of mesocarp was ground with 200 ml of distilled water and 
ethanol separately and allowed to stand for 2 hrs. It was filtered 
through Whatmann No.1 filter paper. The filtrate was then centrifuged 
at 3000 rpm for 10 minutes. Then the supernatant was saved and 
evaporated to dryness in a water bath with reduced temperature.
Peel extract
The P. granatum peel was manually removed; shade dried for 3 days 
and finely powdered using a blender. 10 g of peel powder was mixed 
with 200 ml of distilled water and ethanol separately. This was allowed 
to stand in a dark place for 24 hrs at room temperature with occasional 
stirring. Then, the solution was filtered through Whatmann No.1 filter 
paper followed by centrifugation at 3000 rpm for 10 minutes. Then the 
supernatant was saved and evaporated to dryness in a water bath with 
reduced temperature.
Preliminary phytochemical screening
Preliminary phytochemical screening was performed in the extract 
using the standard methods [10,11].
In vitro antioxidant activity
Antioxidant activity of the extract was measured by 1,1-diphenyl-2-
picryl-hydrazyl (DPPH) radical scavenging method [12] and reducing 
power assay [13]. Tests were carried out in triplicate for separate 
experiments. The amount of extract needed to inhibit free radicals 
concentration by 50%, IC50 was graphically estimated using a non-
linear regression algorithm.
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In vitro thrombolytic activity
Blood samples were collected from healthy volunteers after obtaining 
their consent for the study. Commercially available lyophilized 
streptokinase (Biocon Bangalore) of 15,00,000 I.U., 5 ml of sterile 
distilled water was added and mixed properly. This suspension was 
used as a stock from which 100 µl (30,000 I.U) was prepared for 
in vitro thrombolysis. Experiments for clot lysis were carried as 
reported earlier [27]. Venous blood drawn from healthy volunteers 
was transferred in different pre-weighed sterile eppendorf tube 
(500 µl/tube) and incubated at 37°C for 45 minutes. After clot 
formation, serum was completed removed (aspirated out without 
disturbing the clot formed). Each tube having clot was again weighed 
to determine the clot weight (clot weight=weight of clot containing 
tube-weight of tube alone). Each eppendorf tube containing clot 
was properly labeled, and 100 µl of plant extract was added to the 
tubes. All the tubes were then incubated at 37°C for 60 minutes and 
observed for clot lysis. After incubation, fluid obtained was removed, 
and tubes were again weighed to observe the difference in weight after 
clot disruption. Difference obtained in weight taken before and after 
clot lysis was expressed as a percentage of clot lysis. Streptokinase 
and water were used as a positive and negative (non-thrombolytic) 
control, respectively. The experiment was repeated several times with 
the blood samples of different volunteers.
% clot lysis=(Weight of the lysis clot/Weight of clot before lysis)×100
RESULTS
Preliminary phytochemical investigation of the aqueous and ethanolic 
extract of P. granatum fruit extract revealed the presence of various 
bioactive components. Aqueous extract showed the presence of 
flavanoids, carbohydrates, and saponins, whereas ethanolic extract 
showed the presence of alkaloids, flavanoids, tannins, carbohydrates, 
triterpenoids, steroids, glycosides Vitamin C, and saponins. Similarly, 
aqueous and ethanolic extract of P. granatum peel extract showed the 
presence of flavanoids, glycosides, and Vitamin C. Both the extracts of 
fruit and peel did not show the presence of amino acids and proteins 
(Table 1).
Thrombolytic activity
Table 2 represents clot lysis by the aqueous and ethanolic extract of 
fruit and peel. Maximum thrombolytic activity (60%) was observed 
in ethanolic extract of peel. Streptokinase and water and positive and 
negative control showed 72% and 10%, respectively.
Antioxidant
Table 3 represents DPPH free radical scavenging activity of P. granatum 
fruit extracts peel extract. The free radical scavenging activity of the 
extracts is expressed as percent inhibition. Ethanolic extract of fruit 
at 250 µl/ml showed maximum free radical scavenging activity as 
compared to peel extract, however, lesser than the standard ascorbic 
acid. A dose-dependent increase in free radical scavenging activity of 
fruit and peel extract was observed.
Determination of Na and K in P. granatum fruit and peel extract
The minerals content of pomegranate peel and fruit (aqueous, ethanol) 
extracts were shown in Table 4. The Na concentration was found to 
higher (13.9 ppm) as K (19.9 ppm) in ethanolic extract of the peel.
Reducing power
Table 5 exhibits the reducing power assay of P. granatum fruit 
and peel extract. Reducing power assay is a tool to determine the 
antioxidant capacity of extracts or any other sample. The reducing 
power of both fruit and peel was observed. The ethanolic extract of 
P. granatum fruit and peel showed the highest reducing ability than 
water extract.
The transformation of Fe3+ into Fe2+ in the presence of various extract 
was measured to determine the reducing ability. The reducing ability 
of a compared generally depends on the presence of reductones 
(antioxidants), which exert the antioxidant activity by breaking the 
free radical chain by donating a hydrogen atom [24]. The antioxidant 
Table 1: Preliminary phytochemical screening of 










Alkaloids - - - -
Flavanoids + + + +
Amino acids - - - -
Proteins - - - -
Tannins - + - +
Carbohydrates + + + +
Terpenoids - + - -
Glycosides - + + -
Vitamins - + + -
Saponins + + + -
Steroids - + - +
Table 2: In vitro thrombolytic activity of Punica granatum of 





1 Water (negative control) 10
2 Streptokinase (positive control) 72
3 Fruit extract (aqueous) 33
4 Fruit extract (ethanol) 38
5 Peel extract (aqueous) 34
6 Peel extract (ethanol) 60






Aqueous extract Ethanolic extract Aqueous extract Ethanolic extract
50 7.55 6.25 7.25 5.44 4.21
100 10.22 8.27 9.21 7.41 6.43
150 15.24 14.67 15.43 10.11 9.43
200 18.23 16.43 18.32 13.40 12.23
250 28.21 19.57 22.70 16.11 15.12
DPPH: 1,1-diphenyl-2-picryl-hydrazyl
Table 4: Level of Na and K in Punica granatum fruit and 







1 Fruit extract (aqueous) 6.5 4.8
2 Fruit extract (ethanol) 4.1 12.8
3 Peel extract (aqueous) 8.7 11.9
4 Peel extract (ethanol) 13.9 19.9
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principles present in the fractions of P. granatum caused the reduction 
of Fe3+/ferricyanide complex to the ferrous from, and thus proved the 
reducing ability.
DISCUSSION
The preliminary phytochemical screening tests may be useful in the 
detection of the bioactive principles and subsequently may lead to 
the drug discovery and development. Further, these tests facilitate 
their qualitative separation of pharmacologically active chemical 
compounds [18].
Secondary metabolites in various plants and microorganisms are 
generally evolved in self-defense to avert the toxicity due to adverse 
environmental/physiological conditions. Subsequently, these 
intermediary metabolites also provided a natural platform for the 
development of numerous drugs leading to the treatment of various 
diseases. Methanol extracts of leaf and flower of P. granatum were 
reported to have glycosides, triterpenoids and steroids, saponins, 
alkaloids, flavanoids, tannins, carbohydrate, and Vitamin C. The fruit 
extract showed the abundant occurrence of flavanoids [19]. The 
presence of phytoconstituents in our fruit extracts well agrees with the 
previous reports.
These phytoconstituents might be responsible for different biological 
activities and medicinal importance of this peel. A variety of herbal 
extracts contains different phytochemicals with biological activity that 
can be of valuable therapeutic index [20].
Flavanoids and tannins are phenolic compounds, and plant phenolics 
are a major group of compounds that act as primary antioxidants 
or free radical scavengers. Since these compounds were found to 
be present in the extracts, it might be responsible for the potent 
antioxidant capacity of pomegranate. The secondary metabolites 
and other chemical constituents of medicinal plants account for their 
medicinal value. For example, saponins have hypotensive and cardio 
depressant properties [21]. Glycosides are naturally cardioactive 
drugs used in the treatment of congestive heart failure and cardiac 
arrhythmia.
In our study of thrombolysis, we have tried pomegranate which have 
been using for treating P. granatum was reported to have antithrombotic 
activity, blood purifying property [24].
The prevention of lifestyle-related atherothrombotic diseases such as 
myocardial infarction and stroke is an important and urgent social task 
in many developed countries. Epidemiological studies have provided 
irrefutable evidence for the causative role of inappropriate diet in the 
development and clinical outcome of thrombotic diseases [25]. The 
development of natural products from various plant and animal sources 
which have anti-platelet, anti-coagulant, and thrombolytic activity is 
being studied intensively [26,28].
Reported that recently consumption of phytochemical-rich plant 
foods, including whole grains, vegetables, and fruits, was reported to 
reduce the risk for acute coronary disease incidence, which was closely 
associated with thrombosis [27]. Likewise, P. granatum has a high clot 
lysis (59%) effect. From the results, we concluded that P. granatum has 
antithrombolytic activity.
DPPH radical scavenging activity of an aqueous and ethanolic extract 
of P. granatum fruit extract was found to increase with increasing 
concentration of the extract. This assay was based on the ability of 
DPPH, a stable free radical, to decolorize in the presence of antioxidants, 
which denotes the plant has the antioxidant potential [25].
Sodium is present in most food, and its deficiency is rare. Distorted 
enzymatic activity and poor electrolyte balance of the body fluid are 
related to inadequate Na and K as they are the most required elements 
of living cells [15]. Sodium is an extracellular cation involved in the 
regulation of plasma volume, acid-base balance nerve, and muscle 
contraction. High dietary sodium has been associated with essential 
hypertension [23].
Reducing power is one of the mechanisms for the possible antioxidant 
activity and may serve as a significant indicator of potential antioxidants. 
Ethanolic extract of P. granatum fruit extract showed good concentration 
dependent manner with a perfect reducing power, thus indicating good 
electron donors and ability to terminate radical scavenging reaction [28]. 
The ethanolic extract of fruits of the P. granatum has a significant 
reducing power, which indicates the antioxidant potential of the plant.
CONCLUSION
In our present study, crude extracts of P. granatum fruit and peel were 
screened for phytochemicals; it revealed the presence of flavanoids, 
tannins, and carbohydrates. Both the fruit and peel extracts showed 
antioxidant activity (in vitro) which could be due to the presence of 
phytoconstituents in the extracts. The thrombolytic activity of peel 
extracts was more than the fruit extracts. However, the fruit and peel 
could be used as a better antioxidant and thrombolytic agents.
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100 29.88 12.5 25 34.37 18.75
200 42.33 31.25 31.25 22.23 32.25
300 49.57 46.87 46.87 31.62 55.25
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